J Randal Kirk

Affiliations

  • at Precigen Inc. (PGEN), 2024-08-13
  • Large Shareholder at Aquabounty Technologies Inc. (AQB), 2021-11-24
  • Large Shareholder at Fibrocell Science Inc. (FCSC), 2019-12-17
  • Large Shareholder at Synthetic Biologics Inc. (SYN), 2019-04-03
  • Large Shareholder at Histogenics Corp (HSGX), 2019-01-15
  • Director at Ziopharm Oncology Inc (ZIOP), 2018-10-09
  • Large Shareholder at Precipio Inc. (PRPO), 2018-08-30
  • Large Shareholder at Halozyme Therapeutics Inc (HALO), 2018-08-28
  • Large Shareholder at Soligenix Inc. (SNGX), 2017-05-08
  • Large Shareholder at Ampliphi Biosciences Corp (APHB), 2016-12-30
  • Large Shareholder at Oragenics Inc (OGEN), 2016-07-05
  • Large Shareholder, Director at Clinical Data Inc (CLDA), 2011-04-13
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PGEN $0.85 23,529,411 64,547,214 2024-08-09 Filing
PGEN $1.41 96,686 1,096,686 2023-12-28 Filing
PGEN $1.51 119,411 31,837,786 2023-08-16 Filing
PGEN $1.52 200,000 31,718,375 2023-08-15 Filing
PGEN $1.53 80,589 31,518,375 2023-08-15 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AQB $2.10 9,042 Large Shareholder 3,747 2021-11-23 Filing
AQB $2.10 18,082 Large Shareholder 7,493 2021-11-23 Filing
AQB $2.10 7,323 Large Shareholder 3,035 2021-11-23 Filing
AQB $2.10 14,644 Large Shareholder 6,068 2021-11-23 Filing
AQB $2.10 33,347 Large Shareholder 13,562 2021-11-23 Filing